{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:05:31Z","timestamp":1794024331152,"version":"4.8.0"},"reference-count":191,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gleiberman Head &amp; Neck Cancer Excellence Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cutaneous squamous cell carcinoma (cSCC) manifests through the complex interactions of UV-induced DNA damage, genetic mutations, and alterations in the tumor microenvironment. A high mutational burden is present in cSCC, as well as both cSCC precursors and normal skin, making driver genes difficult to differentiate. Despite this, several key driver genes have been identified, including TP53, the NOTCH family, CDKN2A, PIK3CA, and EGFR. In addition to mutations, the tumor microenvironment and the manipulation and evasion of the immune system play a critical role in cSCC progression. Novel therapeutic approaches, such as immunotherapy and EGFR inhibitors, have been used to target these dysregulations, and have shown promise in treating advanced cSCC cases, emphasizing the need for targeted interventions considering both genetic and microenvironmental factors for improved patient outcomes.<\/jats:p>","DOI":"10.3390\/cancers16162904","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T04:26:57Z","timestamp":1724300817000},"page":"2904","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review"],"prefix":"10.3390","volume":"16","author":[{"given":"Tara M.","family":"Hosseini","sequence":"first","affiliation":[{"name":"Gleiberman Head and Neck Cancer Center, Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo J.","family":"Park","sequence":"additional","affiliation":[{"name":"Gleiberman Head and Neck Cancer Center, Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA"},{"name":"Division of Hematology-Oncology, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1689-3275","authenticated-orcid":false,"given":"Theresa","family":"Guo","sequence":"additional","affiliation":[{"name":"Gleiberman Head and Neck Cancer Center, Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA"},{"name":"Department of Otolaryngology-Head & Neck Surgery, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","article-title":"Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma","volume":"20","author":"Pickering","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous Squamous Cell Carcinoma: Incidence, Risk Factors, Diagnosis, and Staging","volume":"78","author":"Que","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jmg.2010.083022","article-title":"Cancer and neurologic degeneration in xeroderma pigmentosum: Long term follow-up characterizes the role of dna repair","volume":"48","author":"Bradford","year":"2011","journal-title":"J. Med. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40257-016-0207-3","article-title":"Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease","volume":"17","author":"Burton","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41525-021-00226-4","article-title":"The Landscape of Driver Mutations in Cutaneous Squamous Cell Carcinoma","volume":"6","author":"Chang","year":"2021","journal-title":"NPJ Genom. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e2020066","DOI":"10.5826\/dpc.1003a66","article-title":"Squamous Cell Carcinoma: An Update on Diagnosis and Treatment","volume":"10","author":"Combalia","year":"2020","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/jdv.16098","article-title":"Molecular Genetics of Cutaneous Squamous Cell Carcinoma: Perspective for Treatment Strategies","volume":"34","author":"Pellegrini","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Griewank, K.G., Murali, R., Schilling, B., Schimming, T., M\u00f6ller, I., Moll, I., Schwamborn, M., Sucker, A., Zimmer, L., and Schadendorf, D. (2013). TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080354"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Fania, L., Didona, D., Di Pietro, F.R., Verkhovskaia, S., Morese, R., Paolino, G., Donati, M., Ricci, F., Coco, V., and Ricci, F. (2021). Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020171"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.jidsp.5640173","article-title":"Ultraviolet Radiation Induced Signature Mutations in Photocarcinogenesis","volume":"4","author":"Wikonkal","year":"1999","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa2209813","article-title":"Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma","volume":"387","author":"Gross","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s42764-020-00009-8","article-title":"Mechanisms of UV-Induced Mutations and Skin Cancer","volume":"1","author":"Pfeifer","year":"2020","journal-title":"Genome Instab. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/php.12377","article-title":"UV Signature Mutations","volume":"91","author":"Brash","year":"2015","journal-title":"Photochem. Photobiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","article-title":"High Burden and Pervasive Positive Selection of Somatic Mutations in Normal Human Skin","volume":"348","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Shen, Y., Ha, W., Zeng, W., Queen, D., and Liu, L. (2020). Exome Sequencing Identifies Novel Mutation Signatures of UV Radiation and Trichostatin A in Primary Human Keratinocytes. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-61807-4"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Brambullo, T., Colonna, M.R., Vindigni, V., Piaserico, S., Masciopinto, G., Galeano, M., Costa, A.L., and Bassetto, F. (2022). Xeroderma Pigmentosum: A Genetic Condition Skin Cancer Correlated\u2014A Systematic Review. BioMed Res. Int., 2022.","DOI":"10.1155\/2022\/8549532"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/jid.2011.426","article-title":"Shining a Light on Xeroderma Pigmentosum","volume":"132","author":"DiGiovanna","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/0019-5154.113935","article-title":"Reduced P53 Staining in Actinic Keratosis Is Associated with Squamous Cell Carcinoma: A Preliminary Study","volume":"58","author":"Neto","year":"2013","journal-title":"Indian J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.abd.2019.10.004","article-title":"Actinic Keratoses: Review of Clinical, Dermoscopic, and Therapeutic Aspects","volume":"94","author":"Reinehr","year":"2019","journal-title":"Bras. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jid.2020.12.024","article-title":"The Genomic Landscape of Actinic Keratosis","volume":"141","author":"Thomson","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/1523-1747.ep12475717","article-title":"P53 Mutations Are Common and Early Events That Precede Tumor Invasion in Squamous Cell Neoplasia of the Skin","volume":"100","author":"Campbell","year":"1993","journal-title":"J. Investig. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00441-016-2457-z","article-title":"New Perspectives on Role of Tumor Microenvironment in Progression of Cutaneous Squamous Cell Carcinoma","volume":"365","author":"Nissinen","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"eabd7703","DOI":"10.1126\/sciadv.abd7703","article-title":"Ultradeep Sequencing Differentiates Patterns of Skin Clonal Mutations Associated with Sun-Exposure Status and Skin Cancer Burden","volume":"7","author":"Wei","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic Keratoses: Natural History and Risk of Malignant Transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.14852","article-title":"Current Perspective on Actinic Keratosis: A Review","volume":"177","author":"Siegel","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The Genomic Landscape of Cutaneous SCC Reveals Drivers and a Novel Azathioprine Associated Mutational Signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/1940-6207.CAPR-11-0427","article-title":"Functional Protein Pathway Activation Mapping of the Progression of Normal Skin to Squamous Cell Carcinoma","volume":"5","author":"Einspahr","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Janus, J.M., O\u2019Shaughnessy, R.F.L., Harwood, C.A., and Maffucci, T. (2017). Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas. Cancers, 9.","DOI":"10.3390\/cancers9070086"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/bjc.2013.760","article-title":"Key Differences Identified between Actinic Keratosis and Cutaneous Squamous Cell Carcinoma by Transcriptome Profiling","volume":"110","author":"Lambert","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic Analysis of Metastatic Cutaneous Squamous Cell Carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Dong, J., Liao, Y., Wang, H., Zhou, D., Kang, J., and Chen, X. (2022). Identification and Validation of Four Photodynamic Therapy Related Genes Inhibiting MAPK and Inducing Cell Cycle Alteration in Squamous Cell Carcinoma. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.946493"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1126\/science.aau3879","article-title":"Somatic Mutant Clones Colonize the Human Esophagus with Age","volume":"362","author":"Martincorena","year":"2018","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e22257","DOI":"10.1097\/MD.0000000000022257","article-title":"Identification of Potential Gene Drivers of Cutaneous Squamous Cell Carcinoma","volume":"99","author":"Zheng","year":"2020","journal-title":"Medicine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11864-019-0697-3","article-title":"Epidermal Growth Factor Receptor\u2019s Function in Cutaneous Squamous Cell Carcinoma and Its Role as a Therapeutic Target in the Age of Immunotherapies","volume":"21","author":"Joseph","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1038\/s41467-023-40822-9","article-title":"Driver Gene Combinations Dictate Cutaneous Squamous Cell Carcinoma Disease Continuum Progression","volume":"14","author":"Bailey","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.29738","article-title":"Evaluation of 122 Advanced-Stage Cutaneous Squamous Cell Carcinomas by Comprehensive Genomic Profiling Opens the Door for New Routes to Targeted Therapies","volume":"122","author":"Tarasen","year":"2016","journal-title":"Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1038\/ncomms12493","article-title":"Inactivation of TGF\u03b2 Receptors in Stem Cells Drives Cutaneous Squamous Cell Carcinoma","volume":"7","author":"Cammareri","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_39","first-page":"32","article-title":"Molecular Profile of Advanced Cutaneous Squamous Cell Carcinoma","volume":"14","author":"Jones","year":"2021","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.2011.36.7680","article-title":"RAS Mutations Are Associated with the Development of Cutaneous Squamous Cell Tumors in Patients Treated with RAF Inhibitors","volume":"30","author":"Oberholzer","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/jid.2009.312","article-title":"Somatic Mutation of Epidermal Growth Factor Receptor in a Small Subset of Cutaneous Squamous Cell Carcinoma","volume":"130","author":"Ridd","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/cncr.30459","article-title":"Differential Mutation Frequencies in Metastatic Cutaneous Squamous Cell Carcinomas versus Primary Tumors","volume":"123","author":"Yilmaz","year":"2017","journal-title":"Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.ajpath.2015.05.018","article-title":"Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-\u03baB Regulation","volume":"185","author":"Watt","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jaad.2018.08.032","article-title":"TERT Promoter Mutations Are Associated with Poor Prognosis in Cutaneous Squamous Cell Carcinoma","volume":"80","author":"Campos","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s40265-019-01113-0","article-title":"Targeting EGFR and RAS\/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives","volume":"79","author":"Mizukami","year":"2019","journal-title":"Drugs"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.celrep.2014.01.045","article-title":"Pten Loss Induces Autocrine FGF Signaling to Promote Skin Tumorigenesis","volume":"6","author":"Mathew","year":"2014","journal-title":"Cell Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/1078-0432.CCR-11-1344","article-title":"Skin Tumors Induced by Sorafenib; Paradoxic RAS\u2013RAF Pathway Activation and Oncogenic Mutations of HRAS, TP53, and TGFBR1","volume":"18","author":"Arnault","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2133.2007.08360.x","article-title":"Loss of CDKN2A and p14ARF Expression Occurs Frequently in Human Nonmelanoma Skin Cancers","volume":"158","author":"Pacifico","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Campos, M.A., Macedo, S., Fernandes, M.S., Pestana, A., Pardal, J., Batista, R., Vinagre, J., Sanches, A., Baptista, A., and Lopes, J.M. (2020). Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas. Genes, 11.","DOI":"10.3390\/genes11070751"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/15384101.2016.1259892","article-title":"Loss of TGF-\u03b2 Signaling Drives cSCC from Skin Stem Cells\u2014More Evidence","volume":"16","author":"Rose","year":"2016","journal-title":"Cell Cycle"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Olivier, M., Hollstein, M., and Hainaut, P. (2010). TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use. Cold Spring Harb. Perspect. Biol., 2.","DOI":"10.1101\/cshperspect.a001008"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"a026062","DOI":"10.1101\/cshperspect.a026062","article-title":"Tumor-Suppressor Functions of the TP53 Pathway","volume":"6","author":"Aubrey","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/cancers3010994","article-title":"Role of P53 in Cell Death and Human Cancers","volume":"3","author":"Ozaki","year":"2011","journal-title":"Cancers"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Piipponen, M., Riihil\u00e4, P., Nissinen, L., and K\u00e4h\u00e4ri, V.-M. (2021). The Role of P53 in Progression of Cutaneous Squamous Cell Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13184507"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cdd.2017.180","article-title":"Why Are There Hotspot Mutations in the TP53 Gene in Human Cancers?","volume":"25","author":"Baugh","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"P53, the Cellular Gatekeeper for Growth and Division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Pacifico, A., and Leone, G. (2007). Role of P53 and CDKN2A Inactivation in Human Squamous Cell Carcinomas. J. Biomed. Biotechnol., 2007.","DOI":"10.1155\/2007\/43418"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the P53 Tumor Suppressor Gene","volume":"2","author":"Rivlin","year":"2011","journal-title":"Genes. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2133.2007.08267.x","article-title":"Pathology and Pathobiology of Actinic (Solar) Keratosis\u2014An Update","volume":"157","author":"Stockfleth","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Hedberg, M.L., Berry, C.T., Moshiri, A.S., Xiang, Y., Yeh, C.J., Attilasoy, C., Capell, B.C., and Seykora, J.T. (2022). Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073478"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1101\/gad.1484707","article-title":"Notch1 Is a P53 Target Gene Involved in Human Keratinocyte Tumor Suppression through Negative Regulation of ROCK1\/2 and MRCKalpha Kinases","volume":"21","author":"Lefort","year":"2007","journal-title":"Genes Dev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/jid.2014.154","article-title":"NOTCH1 Mutations Occur Early during Cutaneous Squamous Cell Carcinogenesis","volume":"134","author":"South","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Boulay, J.-L., Miserez, A.R., Zweifel, C., Sivasankaran, B., Kana, V., Ghaffari, A., Luyken, C., Sabel, M., Zerrouqi, A., and Wasner, M. (2007). Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain Tumors. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000576"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/annonc\/mdq776","article-title":"Notch1 and Notch2 Have Opposite Prognostic Effects on Patients with Colorectal Cancer","volume":"22","author":"Chu","year":"2011","journal-title":"Ann. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1158\/0008-5472.CAN-04-1446","article-title":"Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth","volume":"64","author":"Fan","year":"2004","journal-title":"Cancer Res."},{"key":"ref_66","first-page":"2452","article-title":"The Intracellular Domains of Notch1 and Notch2 Are Functionally Equivalent during Development and Carcinogenesis","volume":"142","author":"Liu","year":"2015","journal-title":"Development"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Danishevich, A., Bilyalov, A., Nikolaev, S., Khalikov, N., Isaeva, D., Levina, Y., Makarova, M., Nemtsova, M., Chernevskiy, D., and Sagaydak, O. (2023). CDKN2A Gene Mutations: Implications for Hereditary Cancer Syndromes. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123343"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/ijc.24871","article-title":"CDKN2A but Not TP53 Mutations nor HPV Presence Predict Poor Outcome in Metastatic Squamous Cell Carcinoma of the Skin","volume":"126","author":"Verdijk","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_69","unstructured":"(2024, January 30). PubChem CDKN2A\u2014Cyclin Dependent Kinase Inhibitor 2A (Human), Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/gene\/CDKN2A\/human."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/path.4770","article-title":"Cdkn2a Suppresses Metastasis in Squamous Cell Carcinomas Induced by the Gain-of-Function Mutant p53R172H","volume":"240","author":"Li","year":"2016","journal-title":"J. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","article-title":"The PI3K Pathway As Drug Target in Human Cancer","volume":"28","author":"Courtney","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"17297","DOI":"10.1074\/jbc.M610386200","article-title":"AKT-Dependent HspB1 (Hsp27) Activity in Epidermal Differentiation","volume":"282","author":"Welti","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1242\/jcs.03175","article-title":"Regulation of Epidermal Homeostasis and Repair by Phosphoinositide 3-Kinase","volume":"119","author":"Pankow","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Zou, Z., Tao, T., Li, H., and Zhu, X. (2020). mTOR Signaling Pathway and mTOR Inhibitors in Cancer: Progress and Challenges. Cell Biosci., 10.","DOI":"10.1186\/s13578-020-00396-1"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.3892\/ol.2016.5157","article-title":"Potential Impact of mTOR Inhibitors on Cervical Squamous Cell Carcinoma: A Systematic Review","volume":"12","author":"Assad","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Degirmenci, U., Wang, M., and Hu, J. (2020). Targeting Aberrant RAS\/RAF\/MEK\/ERK Signaling for Cancer Therapy. Cells, 9.","DOI":"10.3390\/cells9010198"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"110096","DOI":"10.1016\/j.celrep.2021.110096","article-title":"Identification of RAS Mutant Biomarkers for EGFR Inhibitor Sensitivity Using a Systems Biochemical Approach","volume":"37","author":"McFall","year":"2021","journal-title":"Cell Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.7150\/jca.25083","article-title":"Is Ras a Potential Target in Treatment against Cutaneous Squamous Cell Carcinoma?","volume":"9","author":"Li","year":"2018","journal-title":"J. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/carcin\/bgi220","article-title":"Ultraviolet Irradiation Induces Keratinocyte Proliferation and Epidermal Hyperplasia through the Activation of the Epidermal Growth Factor Receptor","volume":"27","author":"Putta","year":"2006","journal-title":"Carcinogenesis"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/bjd.14936","article-title":"Epidermal Growth Factor Receptor Expression Is Associated with Poor Outcome in Cutaneous Squamous Cell Carcinoma","volume":"176","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000051637","article-title":"Epidermal Growth Factor Receptor Overexpression and Genetic Aberrations in Metastatic Squamous-Cell Carcinoma of the Skin","volume":"202","author":"Shimizu","year":"2001","journal-title":"Dermatology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000355181","article-title":"Treatment of Advanced Cutaneous Squamous Cell Carcinomas with Epidermal Growth Factor Receptor Inhibitors","volume":"227","author":"Alter","year":"2013","journal-title":"Dermatology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1200\/JCO.19.03357","article-title":"Phase II Study of Pembrolizumab as First-Line, Single-Drug Therapy for Patients with Unresectable Cutaneous Squamous Cell Carcinomas","volume":"38","author":"Maubec","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13046-022-02461-8","article-title":"The Diverse Functions of FAT1 in Cancer Progression: Good, Bad, or Ugly?","volume":"41","author":"Chen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Alonso-Juarranz, M., Mascaraque, M., Carrasco, E., Gracia-Caza\u00f1a, T., De La Sen, O., Gilaberte, Y., Gonzalez, S., Juarranz, \u00c1., and Falahat, F. (2023). The Distinctive Features behind the Aggressiveness of Oral and Cutaneous Squamous Cell Carcinomas. Cancers, 15.","DOI":"10.3390\/cancers15123227"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41586-020-03046-1","article-title":"Fat1 Deletion Promotes Hybrid EMT State, Tumour Stemness and Metastasis","volume":"589","author":"Pastushenko","year":"2021","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2017.03.033","article-title":"FAT1 Prevents Epithelial Mesenchymal Transition (EMT) via MAPK\/ERK Signaling Pathway in Esophageal Squamous Cell Cancer","volume":"397","author":"Hu","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/JHC.S398573","article-title":"Comprehensive Genomic Profiling Identifies FAT1 as a Negative Regulator of EMT, CTCs, and Metastasis of Hepatocellular Carcinoma","volume":"10","author":"Huang","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Lazar, A.D., Dinescu, S., and Costache, M. (2020). Deciphering the Molecular Landscape of Cutaneous Squamous Cell Carcinoma for Better Diagnosis and Treatment. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072228"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Liu, H., Liu, Q., Ge, Y., Zhao, Q., Zheng, X., and Zhao, Y. (2016). hTERT Promotes Cell Adhesion and Migration Independent of Telomerase Activity. Sci. Rep., 6.","DOI":"10.1038\/srep22886"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2013.167","article-title":"Mutations of the TERT Promoter Are Common in Basal Cell Carcinoma and Squamous Cell Carcinoma","volume":"27","author":"Scott","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_92","first-page":"393","article-title":"Correlation of Telomere Length to Malignancy Potential in Non-Melanoma Skin Cancers","volume":"15","author":"Nobeyama","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anndiagpath.2015.03.005","article-title":"Heterogeneity of TERT Promoter Mutations Status in Squamous Cell Carcinomas of Different Anatomical Sites","volume":"19","author":"Cheng","year":"2015","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Das Mahapatra, K., Pasquali, L., S\u00f8ndergaard, J.N., Lapins, J., Nemeth, I.B., Balt\u00e1s, E., Kem\u00e9ny, L., Homey, B., Moldovan, L.-I., and Kjems, J. (2020). A Comprehensive Analysis of Coding and Non-Coding Transcriptomic Changes in Cutaneous Squamous Cell Carcinoma. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-59660-6"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Gong, Z.-H., Zhou, F., Shi, C., Xiang, T., Zhou, C.-K., Wang, Q.-Q., Jiang, Y.-S., and Gao, S.-F. (2019). miRNA-221 Promotes Cutaneous Squamous Cell Carcinoma Progression by Targeting PTEN. Cell. Mol. Biol. Lett., 24.","DOI":"10.1186\/s11658-018-0131-z"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.drudis.2018.01.023","article-title":"The microRNA Landscape of Cutaneous Squamous Cell Carcinoma","volume":"23","author":"Konicke","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3892\/ol.2014.2066","article-title":"Inhibition of microRNA-21 Upregulates the Expression of Programmed Cell Death 4 and Phosphatase Tensin Homologue in the A431 Squamous Cell Carcinoma Cell Line","volume":"8","author":"Li","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00109-012-0935-7","article-title":"Down-Regulation of miR-124\/-214 in Cutaneous Squamous Cell Carcinoma Mediates Abnormal Cell Proliferation via the Induction of ERK","volume":"91","author":"Yamane","year":"2013","journal-title":"J. Mol. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2019.01.039","article-title":"Targeting ERK1\/2 Protein-Serine\/Threonine Kinases in Human Cancers","volume":"142","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Neu, J., Dziunycz, P.J., Dzung, A., Lefort, K., Falke, M., Denzler, R., Freiberger, S.N., Iotzova-Weiss, G., Kuzmanov, A., and Levesque, M.P. (2017). miR-181a Decelerates Proliferation in Cutaneous Squamous Cell Carcinoma by Targeting the Proto-Oncogene KRAS. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0185028"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Sancha, N., Corchado-Cobos, R., P\u00e9rez-Losada, J., and Ca\u00f1ueto, J. (2019). MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092181"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jcb.26379","article-title":"MicroRNA-142-5p Induces Cancer Stem Cell-like Properties of Cutaneous Squamous Cell Carcinoma via Inhibiting PTEN","volume":"119","author":"Bai","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng.3091","article-title":"Recurrent Point Mutations in the Kinetochore Gene KNSTRN in Cutaneous Squamous Cell Carcinoma","volume":"46","author":"Lee","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/jdv.15615","article-title":"Somatic Mutations in Kinetochore Gene KNSTRN Are Associated with Basal Proliferating Actinic Keratoses and Cutaneous Squamous Cell Carcinoma","volume":"33","author":"Schmitz","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/annonc\/mdv290","article-title":"BRAF Codons 594 and 596 Mutations Identify a New Molecular Subtype of Metastatic Colorectal Cancer at Favorable Prognosis","volume":"26","author":"Cremolini","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.3892\/ol.2017.6608","article-title":"Mutations in BRAF Codons 594 and 596 Predict Good Prognosis in Melanoma","volume":"14","author":"Wu","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/exd.14272","article-title":"AJUBA: A Regulator of Epidermal Homeostasis and Cancer","volume":"30","author":"Schleicher","year":"2021","journal-title":"Exp. Dermatol."},{"key":"ref_108","unstructured":"(2024, April 05). ARID2 AT-Rich Interaction Domain 2 [Homo Sapiens (Human)]-Gene-NCBI, Available online: https:\/\/www.ncbi.nlm.nih.gov\/gene\/196528."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Stucci, L.S., Intern\u00f2, V., Tucci, M., Perrone, M., Mannavola, F., Palmirotta, R., and Porta, C. (2021). The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice. Genes, 12.","DOI":"10.3390\/genes12050727"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.sjbs.2014.10.002","article-title":"BRAF Gene: From Human Cancers to Developmental Syndromes","volume":"22","author":"Hussain","year":"2015","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Andreassen, P.R., Seo, J., Wiek, C., and Hanenberg, H. (2021). Understanding BRCA2 Function as a Tumor Suppressor Based on Domain-Specific Activities in DNA Damage Responses. Genes, 12.","DOI":"10.3390\/genes12071034"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.smim.2014.03.005","article-title":"Functions of Caspase 8: The Identified and the Mysterious","volume":"26","author":"Salvesen","year":"2014","journal-title":"Semin. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Wang, Z., Li, Y., Peng, H., Liu, J., Zhang, J., and Xiao, X. (2023). The Role of CREBBP\/EP300 and Its Therapeutic Implications in Hematological Malignancies. Cancers, 15.","DOI":"10.3390\/cancers15041219"},{"key":"ref_114","unstructured":"(2024, April 05). Erbb4 Erb-B2 Receptor Tyrosine Kinase 4 [Mus Musculus (House Mouse)]-Gene-NCBI, Available online: https:\/\/www.ncbi.nlm.nih.gov\/gene\/13869."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/cas.14840","article-title":"The Noncanonical Role of EZH2 in Cancer","volume":"112","author":"Huang","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"102530","DOI":"10.1016\/j.ctrv.2023.102530","article-title":"Role of FGFR3 in Bladder Cancer: Treatment Landscape and Future Challenges","volume":"115","author":"Ascione","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"zcac023","DOI":"10.1093\/narcan\/zcac023","article-title":"KMT2C-Deficient Tumors Have Elevated APOBEC Mutagenesis and Genomic Instability in Multiple Cancers","volume":"4","author":"Hu","year":"2022","journal-title":"NAR Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"17588359211038477","DOI":"10.1177\/17588359211038477","article-title":"TGFBR2 Mutation Predicts Resistance to Immune Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer","volume":"13","author":"Li","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGF\u03b2 Signalling in Context","volume":"13","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Loesch, R., Chenane, L., and Colnot, S. (2020). ARID2 Chromatin Remodeler in Hepatocellular Carcinoma. Cells, 9.","DOI":"10.3390\/cells9102152"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"6729717","DOI":"10.1155\/2023\/6729717","article-title":"KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer","volume":"2023","author":"Zhang","year":"2023","journal-title":"Dis. Markers"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41698-020-0119-9","article-title":"Decreased Cytotoxic T Cells and TCR Clonality in Organ Transplant Recipients with Squamous Cell Carcinoma","volume":"4","author":"Frazzette","year":"2020","journal-title":"NPJ Precis. Oncol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/CJI.0b013e3181cc2615","article-title":"Immunosuppression Affects CD4+ mRNA Expression and Induces Th2 Dominance in the Microenvironment of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients","volume":"33","author":"Kosmidis","year":"2010","journal-title":"J. Immunother."},{"key":"ref_124","first-page":"405","article-title":"Altered Density, Composition and Microanatomical Distribution of Infiltrating Immune Cells in Cutaneous Squamous Cell Carcinoma of Organ Transplant Recipients","volume":"179","author":"Strobel","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5021\/ad.22.175","article-title":"The Tumor Immune Microenvironment in Cutaneous Squamous Cell Carcinoma Arising in Organ Transplant Recipients","volume":"35","author":"Zilberg","year":"2023","journal-title":"Ann. Dermatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2014.09.010","article-title":"Incidence and Risk Factors for Skin Cancer Following Lung Transplantation","volume":"72","author":"Rashtak","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/ijc.33934","article-title":"Cancer Risk and Mortality after Solid Organ Transplantation: A Population-Based 30-Year Cohort Study in Finland","volume":"150","author":"Friman","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The Tumor Microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Nieto, G.A., Teppo, H.-R., Petrelius, N., Izzi, V., Devarajan, R., Pet\u00e4ist\u00f6, T., Liu, H., Kim, K.S., Karppinen, S.-M., and Ruotsalainen, H. (2022). Upregulated Integrin A11 in the Stroma of Cutaneous Squamous Cell Carcinoma Promotes Skin Carcinogenesis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.981009"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1242\/jcs.023820","article-title":"The Extracellular Matrix at a Glance","volume":"123","author":"Frantz","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2041731414557112","DOI":"10.1177\/2041731414557112","article-title":"The Extracellular Matrix: Structure, Composition, Age-Related Differences, Tools for Analysis and Applications for Tissue Engineering","volume":"5","author":"Kular","year":"2014","journal-title":"J. Tissue Eng."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/kei025","article-title":"Levels of Matrix Metalloproteinase (MMP)-1 in Paired Sera and Synovial Fluids of Juvenile Idiopathic Arthritis Patients: Relationship to Inflammatory Activity, MMP-3 and Tissue Inhibitor of Metalloproteinases-1 in a Longitudinal Study","volume":"44","author":"Peake","year":"2005","journal-title":"Rheumatology"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Wang, H., Li, H., Yan, Q., Gao, S., Gao, J., Wang, Z., and Sun, Y. (2021). Serum Matrix Metalloproteinase-13 as a Diagnostic Biomarker for Cutaneous Squamous Cell Carcinoma. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08566-1"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Fromme, J.E., and Zigrino, P. (2022). The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.864302"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Lu, P., Takai, K., Weaver, V.M., and Werb, Z. (2011). Extracellular Matrix Degradation and Remodeling in Development and Disease. Cold Spring Harb. Perspect. Biol., 3.","DOI":"10.1101\/cshperspect.a005058"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Birbrair, A. (2020). Tumour Microenvironment in Skin Carcinogenesis. Tumor Microenvironments in Organs: From the Brain to the Skin\u2014Part A, Springer International Publishing.","DOI":"10.1007\/978-3-030-59038-3"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2340\/00015555-1597","article-title":"Comparison of Immunosuppressive and Immunomodulatory Cells in Keratoacanthoma and Cutaneous Squamous Cell Carcinoma","volume":"93","author":"Kambayashi","year":"2013","journal-title":"Acta Derm.-Venereol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/jid.2011.9","article-title":"Tumor-Associated Macrophages in the Cutaneous SCC Microenvironment Are Heterogeneously Activated","volume":"131","author":"Pettersen","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.oooo.2014.12.019","article-title":"MMP-7, MMP-8, and MMP-9 in Oral and Cutaneous Squamous Cell Carcinomas","volume":"119","author":"Haglund","year":"2015","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Ricard-Blum, S. (2011). The Collagen Family. Cold Spring Harb. Perspect. Biol., 3.","DOI":"10.1101\/cshperspect.a004978"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/exd.12913","article-title":"Collagens XV and XVIII Show Different Expression and Localisation in Cutaneous Squamous Cell Carcinoma: Type XV Appears in Tumor Stroma, While XVIII Becomes Upregulated in Tumor Cells and Lost from Microvessels","volume":"25","author":"Karppinen","year":"2016","journal-title":"Exp. Dermatol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"djv293","DOI":"10.1093\/jnci\/djv293","article-title":"Suppression of TGF\u03b2 and Angiogenesis by Type VII Collagen in Cutaneous SCC","volume":"108","author":"Martins","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal Fibroblasts in Cancer Initiation and Progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Gallego-Rentero, M., Guti\u00e9rrez-P\u00e9rez, M., Fern\u00e1ndez-Guarino, M., Mascaraque, M., Portillo-Esnaola, M., Gilaberte, Y., Carrasco, E., and Juarranz, \u00c1. (2021). TGF\u03b21 Secreted by Cancer-Associated Fibroblasts as an Inductor of Resistance to Photodynamic Therapy in Squamous Cell Carcinoma Cells. Cancers, 13.","DOI":"10.3390\/cancers13225613"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological Hallmarks of Stromal Cells in the Tumour Microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Hirayama, D., Iida, T., and Nakase, H. (2017). The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010092"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1158\/0008-5472.CAN-10-0269","article-title":"Notch Signaling Determines the M1 versus M2 Polarization of Macrophages in Antitumor Immune Responses","volume":"70","author":"Wang","year":"2010","journal-title":"Cancer Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.3989","article-title":"Vascular Endothelial Growth Factor-Induced Skin Carcinogenesis Depends on Recruitment and Alternative Activation of Macrophages","volume":"227","author":"Linde","year":"2012","journal-title":"J. Pathol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/jid.2010.266","article-title":"The Human Cutaneous Squamous Cell Carcinoma Microenvironment Is Characterized by Increased Lymphatic Density and Enhanced Expression of Macrophage-Derived VEGF-C","volume":"131","author":"Moussai","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage Polarization: Tumor-Associated Macrophages as a Paradigm for Polarized M2 Mononuclear Phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/DSS.0000000000000371","article-title":"Density and Polarization States of Tumor-Associated Macrophages in Human Cutaneous Squamous Cell Carcinomas Arising in Solid Organ Transplant Recipients","volume":"42","author":"Cyrus","year":"2016","journal-title":"Dermatol. Surg."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Boutilier, A.J., and Elsawa, S.F. (2021). Macrophage Polarization States in the Tumor Microenvironment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136995"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1600-0714.2010.00879.x","article-title":"Association of Macrophages with Angiogenesis in Oral Verrucous and Squamous Cell Carcinomas","volume":"39","year":"2010","journal-title":"J. Oral Pathol. Med."},{"key":"ref_154","first-page":"4625","article-title":"Association of Macrophage Infiltration with Angiogenesis and Prognosis in Invasive Breast Carcinoma","volume":"56","author":"Leek","year":"1996","journal-title":"Cancer Res."},{"key":"ref_155","first-page":"445","article-title":"Tumor Associated Macrophages in Human Prostate Cancer: Relation to Clinicopathological Variables and Survival","volume":"17","author":"Lissbrant","year":"2000","journal-title":"Int. J. Oncol."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Saeidi, V., Doudican, N., and Carucci, J.A. (2023). Understanding the Squamous Cell Carcinoma Immune Microenvironment. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1084873"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.oraloncology.2012.09.012","article-title":"Tumor-Associated Macrophages and the Profile of Inflammatory Cytokines in Oral Squamous Cell Carcinoma","volume":"49","author":"Costa","year":"2013","journal-title":"Oral Oncol."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Kumar, A.T., Knops, A., Swendseid, B., Martinez-Outschoom, U., Harshyne, L., Philp, N., Rodeck, U., Luginbuhl, A., Cognetti, D., and Johnson, J. (2019). Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00656"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Fujimura, T., Kambayashi, Y., Fujisawa, Y., Hidaka, T., and Aiba, S. (2018). Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00003"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Zhang, S., Fujita, H., Mitsui, H., Yanofsky, V.R., Fuentes-Duculan, J., Pettersen, J.S., Su\u00e1rez-Fari\u00f1as, M., Gonzalez, J., Wang, C.Q.F., and Krueger, J.G. (2013). Increased Tc22 and Treg\/CD8 Ratio Contribute to Aggressive Growth of Transplant Associated Squamous Cell Carcinoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062154"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific Recruitment of Regulatory T Cells in Ovarian Carcinoma Fosters Immune Privilege and Predicts Reduced Survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","article-title":"Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse","volume":"24","author":"Bates","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased Regulatory T Cells Correlate with CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-08-2360","article-title":"Regulatory T Cells Recruited through CCL22\/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome","volume":"69","author":"Gobert","year":"2009","journal-title":"Cancer Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1158\/1078-0432.CCR-15-2614","article-title":"OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T Cell Responses and Associate with Metastatic Potential","volume":"22","author":"Lai","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/cmi.2018.170","article-title":"Immune Regulation by CD8+ Treg Cells: Novel Possibilities for Anticancer Immunotherapy","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell Mol. Immunol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cell.2020.05.039","article-title":"Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma","volume":"182","author":"Ji","year":"2020","journal-title":"Cell"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/mc.23528","article-title":"Natural Killer Cells Suppress Human Cutaneous Squamous Cell Carcinoma Cancer Cell Survival and Tumor Growth","volume":"62","author":"Adhikary","year":"2023","journal-title":"Mol. Carcinog."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jid.2021.03.018","article-title":"Cutaneous Squamous Cell Carcinoma Development Is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfunctions","volume":"141","author":"Luci","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PPO.0000000000000610","article-title":"Natural Killer Cell Recognition and Control of Epithelial Cancers","volume":"28","author":"Carr","year":"2022","journal-title":"Cancer J."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jdcr.2017.04.006","article-title":"Exploring the Relationship between Natural Killer Cells and Cutaneous Squamous Cell Carcinoma Development","volume":"3","author":"Ilyas","year":"2017","journal-title":"JAAD Case Rep."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Khou, S., Popa, A., Luci, C., Bihl, F., Meghraoui-Kheddar, A., Bourdely, P., Salavagione, E., Cosson, E., Rubod, A., and Cazareth, J. (2020). Tumor-Associated Neutrophils Dampen Adaptive Immunity and Promote Cutaneous Squamous Cell Carcinoma Development. Cancers, 12.","DOI":"10.3390\/cancers12071860"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jdermsci.2016.04.013","article-title":"Cutaneous Squamous Cell Carcinomas with Markers of Increased Metastatic Risk Are Associated with Elevated Numbers of Neutrophils and\/or Granulocytic Myeloid Derived Suppressor Cells","volume":"83","author":"Seddon","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.19.03054","article-title":"Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)","volume":"38","author":"Grob","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1200\/JCO.2010.34.1735","article-title":"Phase II Study of Cetuximab as First-Line Single-Drug Therapy in Patients with Unresectable Squamous Cell Carcinoma of the Skin","volume":"29","author":"Maubec","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/annonc\/mdu368","article-title":"Phase II Study of Single-Agent Panitumumab in Patients with Incurable Cutaneous Squamous Cell Carcinoma","volume":"25","author":"Foote","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/cncr.31346","article-title":"Erlotinib in the Treatment of Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single Arm Phase II Clinical Trial","volume":"124","author":"Gold","year":"2018","journal-title":"Cancer"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaad.2017.07.048","article-title":"Gefitinib for Patients with Incurable Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Clinical Trial","volume":"77","author":"William","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.canrad.2012.06.005","article-title":"Radiotherapy Combined with Cetuximab for Locally Advanced Head and Neck Cancer: Results and Toxicity","volume":"16","author":"Valette","year":"2012","journal-title":"Cancer Radiother."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1470-2045(21)00136-4","article-title":"Pembrolizumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-Label, Multi-Arm, Non-Randomised, Multicentre, Phase 2 Trial","volume":"22","author":"Sacco","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-21-3849","article-title":"Phase II Multi-Institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and\/or Metastatic Head and Neck Squamous Cell Carcinoma","volume":"28","author":"Chung","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"e2021169S","DOI":"10.5826\/dpc.11S2a169S","article-title":"Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma","volume":"11","author":"Morse","year":"2021","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40257-019-00426-w","article-title":"Immune Checkpoint Inhibitors for Treating Advanced Cutaneous Squamous Cell Carcinoma","volume":"20","author":"Patel","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_185","unstructured":"Center for Drug Evaluation and Research (2019). FDA Approves Cemiplimab-Rwlc for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma, FDA."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant\u2013Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma","volume":"388","author":"Patel","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Marin-Acevedo, J.A., Withycombe, B.M., Kim, Y., Brohl, A.S., Eroglu, Z., Markowitz, J., Tarhini, A.A., Tsai, K.Y., and Khushalani, N.I. (2023). Cetuximab for Immunotherapy-Refractory\/Ineligible Cutaneous Squamous Cell Carcinoma. Cancers, 15.","DOI":"10.3390\/cancers15123180"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1517\/14712598.2013.876406","article-title":"Update of Cetuximab for Non-Melanoma Skin Cancer","volume":"14","author":"Wollina","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"709","DOI":"10.18632\/oncotarget.28470","article-title":"Effectiveness and Toxicity of Cetuximab with Concurrent RT in Locally Advanced Cutaneous Squamous Cell Skin Cancer: A Case Series","volume":"14","author":"Chang","year":"2023","journal-title":"Oncotarget"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"901","DOI":"10.36849\/JDD.6175","article-title":"Combining Panitumumab with Anti-PD-1 Antibody in Cutaneous Squamous Cell Carcinoma of the Head and Neck after Inadequate Response to Anti-PD-1 Antibody Alone","volume":"20","author":"Hsu","year":"2021","journal-title":"J. Drugs Dermatol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/16\/2904\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:40:19Z","timestamp":1760110819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/16\/2904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":191,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["cancers16162904"],"URL":"https:\/\/doi.org\/10.3390\/cancers16162904","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}